Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 21, 2025
Reporting period
Not applicable
Filed with the SEC
Oct 24, 2025
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001022079-25-000225
Filed / recorded
Oct 24, 2025, 10:09 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
QUEST DIAGNOSTICS INC
Issuer CIK
1022079
Ticker
DGX
Reporting person
Mark E Delaney
Relationship
Officer
Officer title
SVP & Chief Commercial Officer
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Oct 21, 2025
Transaction code
A
Shares / units
15
Price per share
$189.077
Acquired / disposed
Acquired (A)
Shares owned after
7,530
Ownership form
Direct
Amendment
No
Footnotes from the filing
Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
